
Sign up to save your podcasts
Or


Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.
By The Motley Fool4.7
16041,604 ratings
Though currently littered with penny stocks, the landscape for investing in marijuana is improving. Shannon Jones analyzes the recent merger of Aurora Cannabis and MedReleaf, and the impending FDA approval for GW Pharmaceuticals. Plus, we discuss how professional athletes and owners are helping the case by becoming more vocal about marijuana as a device for pain management.

3,223 Listeners

1,500 Listeners

806 Listeners

951 Listeners

521 Listeners

1,178 Listeners

2,168 Listeners

826 Listeners

1,417 Listeners

1,040 Listeners

9,627 Listeners

192 Listeners

809 Listeners

76 Listeners

40 Listeners

988 Listeners

44 Listeners